OPPENHEIMER & CO INC - PERNIX THERAPEUTICS HLDGS IN ownership

PERNIX THERAPEUTICS HLDGS IN's ticker is PTX and the CUSIP is 71426V108. A total of 90 filers reported holding PERNIX THERAPEUTICS HLDGS IN in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
OPPENHEIMER & CO INC ownership history of PERNIX THERAPEUTICS HLDGS IN
ValueSharesWeighting
Q3 2016$8,000
+14.3%
13,500
-8.2%
0.00%
Q2 2016$7,000
-61.1%
14,700
-16.9%
0.00%
-100.0%
Q1 2016$18,000
-72.7%
17,700
-20.3%
0.00%
-50.0%
Q4 2015$66,000
-13.2%
22,200
-6.9%
0.00%0.0%
Q3 2015$76,000
-37.2%
23,850
+17.2%
0.00%
-33.3%
Q2 2015$121,000
+12.0%
20,350
+101.5%
0.00%0.0%
Q1 2015$108,00010,1000.00%
Other shareholders
PERNIX THERAPEUTICS HLDGS IN shareholders Q1 2016
NameSharesValueWeighting ↓
Sageview Capital 2,223,339$5,603,0001.59%
Orbimed Advisors 2,320,800$5,848,0000.09%
F&C Asset Management plc 1,854,808$4,665,0000.06%
SPHERA FUNDS MANAGEMENT LTD. 56,500$142,0000.04%
Yakira Capital Management, Inc. 11,957$30,0000.03%
Spectrum Management Group, LLC 10,000$25,0000.02%
Weiss Multi-Strategy Advisers LLC 41,152$104,0000.00%
WOLVERINE ASSET MANAGEMENT LLC 30,000$75,0000.00%
PUTNAM INVESTMENTS LLC 129,762$327,0000.00%
Partnervest Advisory Services LLC 220$1,0000.00%
View complete list of PERNIX THERAPEUTICS HLDGS IN shareholders